Further, over the past two decades, only a handful of research groups have performed in-depth studies regarding this peptide
See the Melanotan II peptide profile for receptor detail
1 H NMR (400 MHz, DMSO) 8.74 (s, 1H), 8.22 (d, J = 8.3 Hz, 1H), 7.50 7.39 (m, 9H), 7.22 (s, 1H), 7.18 7.09 (m, 6H), 6.91 (t, J = 6.0 Hz, 1H), 4.57 (td, J = 9.0, 4.8 Hz, 1H), 3.50 (d, J = 10.9 Hz, 2H), 3.14 (dd, J = 15.0, 4.9 Hz, 1H), 2.94 (dd, J = 15.0, 9.8 Hz, 1H), 1.34 (s, 9H)
For a deeper dive, explore The Benefits of Vitamin B12: What You Need to Know
Long-term cardiovascular safety wont be confirmed until TRIUMPH-CVOT reports, expected in 2028 at the earliest
Ideal candidates might include those who: Have documented binge eating episodes causing significant distress Meet BMI criteria for weight management medications Have not responded adequately to psychological interventions (such as cognitive behavioural therapy) Do not have contraindications to GLP-1 therapy Understand the off-label nature of this indication UK SmPCs for GLP-1 medications note findings of thyroid C-cell tumours in rodent studies, though the relevance to humans remains uncertain